Page last updated: 2024-08-16

mitomycin and capecitabine

mitomycin has been researched along with capecitabine in 70 studies

Research

Studies (70)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's19 (27.14)29.6817
2010's44 (62.86)24.3611
2020's7 (10.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hehlmann, R; Hochhaus, A; Hofheinz, RD; Weisser, A; Willer, A1
Brasiūnas, V; Brasiūniene, B; Inciūra, A; Juozaityte, E1
Depisch, D; Gruenberger, T; Karall, K; Kornek, GV; Laengle, F; Lang, F; Penz, M; Scheithauer, W; Schuell, B1
Bokemeyer, C; Gnad, U; Hartmann, JT; Hartung, G; Hehlmann, R; Hochhaus, A; Hofheinz, RD; Kreil, S; Oechsle, K; Saussele, S; Willer, A1
Cunningham, D; Hill, ME; Norman, AR; Oates, J; Price, T; Rao, S; Ross, PJ; Shellito, P; Tebbutt, N1
Chen, AJ; Hu, MD; Li, L; Li, XY; Ran, JH; Sun, F; Tang, JH1
Im, YH; Ji, SH; Jung, CW; Kang, JH; Kang, WK; Kim, K; Kim, WS; Lee, J; Lee, SH; Lim, DH; Park, BB; Park, JO; Park, K; Park, KW; Park, YS1
Chong, G; Cunningham, D; Dickson, JL; Hill, ME; Norman, AR; Oates, J; Price, TJ; Rao, S; Tebbutt, N1
Fukumitsu, T; Ishibashi, N; Matono, K; Mizobe, T; Ogata, Y; Sasatomi, T; Shirouzu, K; Torigoe, S; Yamashita, N; Yanagawa, T1
Alliot, C1
Burattini, L; La Cesa, A; Marcucci, F; Massacesi, C; Pilone, A; Rocchi, MB; Santini, D; Tonini, G; Zepponi, L1
Aravindan, N; Dang, A; Hightower, C; Ilsin, B; Mansfield, P; Rice, D; Riedel, B1
Ernst, T; Gnad-Vogt, U; Hochhaus, A; Hofheinz, RD; Kripp, M; Lukan, N; Merx, K; Schultheis, B1
Glynne-Jones, R; Gollins, S; Leslie, M; Levine, E; McDonald, AC; Meadows, H; Myint, S; Samuel, L; Sebag-Montefiore, D; Wan, S1
Farquharson, AL; O'Dwyer, ST; Pranesh, N; Renehan, AG; Rout, S; Saunders, MP; Swindell, R; Taylor, MB; Wilson, MS; Witham, G1
Cohen, SJ; Konski, A; Li, T; Meropol, NJ; Sigurdson, E; Small, W; Spies, S; Stryker, S; Wahl, A; Yu, JQ1
Davies, JM; Goldberg, RM1
Halverson, AL; Hogg, ME; Kiel, KD; Popowich, DA; Stryker, SJ; Wang, EC1
Arce-Lara, C; Bekaii-Saab, T; Cataland, S; Kraut, E; Ntukidem, N; Otterson, GA1
Bekaii-Saab, T; Campbell, A; Hill, M; Kosuri, K; Thomas, J; Villalona-Calero, M1
Arai, T; Hirai, H; Imagaki, K; Iwasawa, Y; Kobayashi, M; Kotani, H; Mizuarai, S; Nishibata, T; Ohtani, J; Okada, M; Sakai, N; Sakai, T; Yoshizumi, T1
Ernst, T; Hochhaus, A; Hofheinz, RD; Hofmann, WK; Kripp, M; Kruth, J; Lukan, N; Merx, K; Nissen, J1
Chan, AK; Jenken, DA; Wong, AO1
Ackland, SP; Broad, A; Chua, Y; Cummins, MM; Cunningham, D; Forgeson, G; Ganju, V; Gebski, VJ; Price, TJ; Robinson, B; Saunders, MP; Simes, RJ; Stockler, MR; Tebbutt, NC; van Hazel, GA; Wilson, K; Zalcberg, JR; Zannino, D1
Abahssain, H; Afchain, P; Errihani, H; Ismaili, N; Melas, N; Rabti, HM; Rahali, R1
Borojevic, N; Gavrilovic, D; Kecmanovic, D; Kezic, I; Krivokapic, Z; Micev, M; Nikolic, V; Popov, I; Radosevic-Jelic, L; Stojanovic, S1
Boban, M; Boskovic, L; Fridl-Vidas, V; Hrepic, D; Omrcen, T; Vrdoljak, E1
Alfa-Wali, M; Allen-Mersh, T; Antoniou, A; Bower, M; Gazzard, B; Nelson, M; Newsom-Davis, T; Tait, D1
Chua, A; Cummins, MM; Hardingham, JE; Lee, CK; Murone, C; Price, TJ; Shivasami, A; Tebbutt, NC; Townsend, AR; Weickhardt, A; Wrin, JW1
Peeters, M; Price, T1
Créhange, G; Dalban, C; Dewas, CV; Dewas, S; Khoury, C; Maingon, P; Martin, E; Peignaux, K; Petitfils, A; Truc, G1
Beijnen, JH; Boot, H; Cats, A; Deenen, MJ; Dewit, L; Schellens, JH1
Cassidy, J; Hochster, H1
Brennan, M; Garcon, MC; Kaley, K; Rodriguez, G; Saif, MW1
Chindaprasirt, J; Khuntikeo, N; Ngamprasertchai, T; Pakkhem, A; Sookprasert, A; Ungarereevittaya, P; Wirasorn, K1
Hardingham, JE; Lee, CK; Murone, C; Price, TJ; Simes, RJ; Tebbutt, NC; Townsend, AR; Weickhardt, A; Wilson, K; Wrin, JW1
Carter, HE; Howard, K; John Simes, R; Price, TJ; Schofield, DJ; Tebbutt, NC; Zalcberg, JR; Zannino, D1
Call, JA; Goodman, KA; Jabbour, SK; Jacob, R; Jensen, LG; Mell, LK; Miller, RC; Ord, CB; Prendergast, BM; Thomas, CR1
Al-Batran, SE; Gencer, D; Hartmann, JT; Hochhaus, A; Hofheinz, RD; Kripp, M; Merx, K; Miranda, MB1
Follwell, M; Johal, B; Kennecke, HF; Thind, G1
Bydder, G; Bydder, M; Carmona, R; Gulaya, S; Mell, LK; Pritz, J; Vaida, F; Welch, CS; Williamson, CW; Zhu, H1
Beijnen, JH; Cats, A; Dewit, L; Meulendijks, D; Schellens, JH; Tomasoa, NB; van Tinteren, H1
Ahlgren, J; Akin, E; Bishop, C; Guebre-Xabiher, H; Kirkel, D; Patel, N; Schuck, S; Siegel, P; Siegel, R; Simmens, S1
Bruhn, MA; Cunningham, D; Gebski, V; Hardingham, JE; Lee, CK; Mann, KP; Price, TJ; Robinson, B; Simes, J; Tebbutt, NC; Townsend, AR; Van Hazel, G; Weickhardt, A; Wilson, K; Wrin, JW1
Asadi, K; Chionh, F; Lee, CK; Mariadason, JM; Murone, C; Nagtegaal, ID; Parry, MM; Price, TJ; Punt, CJ; Scott, AM; Simes, J; Tebbutt, NC; Weickhardt, AJ; Williams, DS; Wilson, K1
Aldrighetti, L; Aprile, G; Auriemma, A; Belli, C; Cereda, S; Cordio, S; Galiano, A; Leone, F; Lutrino, SE; Marino, D; Martines, C; Milella, M; Mosconi, S; Novarino, A; Palazzo, V; Reinach, B; Reni, M; Santini, D; Vaccaro, V; Vasile, E1
Alex, AK; Bariani, G; Braghirolli, MI; Hoff, PM; Moniz, CM; Nahas, C; Oliveira, SC; Riechelmann, R1
Almstedt, K; Bayer, CM; Beckmann, MW; Fasching, PA; Hack, CC; Hein, A; Jud, SM; Lux, MP; Rack, B; Rauh, C; Scharl, A; Schrauder, MG1
Goodman, KA; Julie, DR1
Bouchaab, H; Bourhis, J; De Bari, B; Hanhloser, D; Jumeau, R; Matzinger, O; Mirimanoff, RO; Ozsahin, EM; Troussier, I; Vallet, V; Wagner, AD1
Barni, S; Ghidini, A; Inno, A; Petrelli, F1
Bosset, JF; Huguet, F; Loganadane, G; Schernberg, A; Servagi-Vernat, S; Touboul, E1
Ihemelandu, C; Sugarbaker, PH1
Aggarwal, S; Bazan, JG; Chang, DT; Golden, DW; Kopec, M; Lee, AY; Liauw, SL; Pelizzari, CA1
Chong, LC; Healey, T; Michele, T; Price, TJ1
Abdel-Rahman, O; Elhalawani, H; Elsayed, Z1
Adams, R; Downing, A; Gilbert, DC; Glynne-Jones, R; Harrison, M; Hawkins, M; Jones, CM; Muirhead, R; Sebag-Montefiore, D1
Arcadipane, F; Casadei Gardini, A; Cassoni, P; Ceccarelli, M; Créhange, G; De Bari, B; Evangelista, A; Franco, P; Furfaro, G; Iorio, GC; Lepinoy, A; Martini, S; Mistrangelo, M; Passardi, A; Ricardi, U; Trino, E; Valgiusti, M1
Asher, R; Buchanan, D; Hardingham, J; Lee, CK; Mariadason, JM; Mooi, JK; Price, TJ; Savas, P; Tebbutt, NC; Tejpar, S; Townsend, A; Williams, D; Wirapati, P1
Abdel-Wahab, M; Anker, CJ; Azad, N; Bianchi, N; Das, P; Dragovic, J; Goodman, KA; Jabbour, SK; Jones, W; Kennedy, T; Kumar, R; Lee, P; Russo, S; Sharma, N; Small, W; Suh, WW1
Mertens, LS; Noordzij, A; Pos, F; Schaake, EE; Schuring, N; van de Kamp, MW; van der Heijden, MS; van Rhijn, BWG; Voskuilen, CS1
Evans, S; Nagourney, AJ; Nagourney, RA; Sugarbaker, PH; Tran, PH1
Aalbers, AGJ; Bakkers, C; Boerma, D; Brandt-Kerkhof, ARM; Bremers, AJA; Buffart, TE; Burger, JWA; Creemers, GM; de Groot, DJA; de Hingh, IHJT; de Reuver, PR; Dijkgraaf, MGW; Fijneman, RJA; Hemmer, PHJ; Kok, NFM; Koopman, M; Kranenburg, O; Kruijff, S; Kusters, M; Lahaye, MJ; Los, M; Madsen, EVE; Nederend, J; Nienhuijs, SW; Punt, CJA; Rovers, KP; Snaebjornsson, P; Tanis, PJ; Thijs, AMJ; Tuynman, JB; van 't Erve, I; van Grevenstein, WMU; van Meerten, E; Verheul, HMW; Versteeg, KS; Wiezer, MJ; Witkamp, AJ1
Bins, AD; de Reijke, TM; de Ruiter, BM; Donker, M; Hulshof, MCCM; Lipman, D; Maartje Piet, AH; Oddens, JR; van der Hulle, T; van Gennep, EJ; van Hattum, JW; van Moorselaar, RJA; Voortman, J1
Ben David, MA; Grinberg, V; Hod, K; Kalmus, Y; Levin, D; Lipski, Y; Pfeffer, RM; Schlosser, S; Zalmanov, S1
Baratti, D; Delfanti, S; Deraco, M; Di Bartolomeo, M; Galassi, M; Ghelardi, F; Greco, GF; Guaglio, M; Intini, R; Lampis, BR; Leoncini, G; Mazzoli, G; Milione, M; Morano, F; Nannini, M; Nasca, V; Pannone, A; Pietrantonio, F; Raimondi, A; Randon, G; Sabella, G1
Belkacemi, M; Bentaleb, N; Boustany, R; Mineur, L; Plat, F; Toullec, C; Vazquez, L1

Reviews

14 review(s) available for mitomycin and capecitabine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[The update on pancreatic cancer chemotherapy].
    Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:10

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Cisplatin; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Ifosfamide; Infusions, Intra-Arterial; Irinotecan; Male; Mitomycin; Multicenter Studies as Topic; Pancreatic Neoplasms; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Taxoids; Time Factors

2003
First-line therapeutic strategies in metastatic colorectal cancer.
    Oncology (Williston Park, N.Y.), 2008, Nov-30, Volume: 22, Issue:13

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Camptothecin; Capecitabine; Celecoxib; Cetuximab; Clinical Trials as Topic; Colorectal Neoplasms; Deoxycytidine; Erlotinib Hydrochloride; Fluorouracil; Humans; Irinotecan; Leucovorin; Meta-Analysis as Topic; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Prognosis; Pyrazoles; Quinazolines; Randomized Controlled Trials as Topic; Sulfonamides; Survival Analysis; Treatment Outcome; Vitamin B Complex

2008
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Clinical Trials as Topic; Deoxycytidine; Fluorouracil; Hemolytic-Uremic Syndrome; Humans; Irinotecan; Mitomycin; Prospective Studies; Purpura, Thrombotic Thrombocytopenic

2010
[Chemotherapy in gallbladder carcinoma].
    Presse medicale (Paris, France : 1983), 2010, Volume: 39, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Capecitabine; Cisplatin; Deoxycytidine; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Leucovorin; Mitomycin; Neoplasm Invasiveness; Neoplasm Staging; Randomized Controlled Trials as Topic; Survival Rate; Treatment Outcome

2010
Biologic therapies in the metastatic colorectal cancer treatment continuum--applying current evidence to clinical practice.
    Cancer treatment reviews, 2012, Volume: 38, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Cetuximab; Colorectal Neoplasms; Deoxycytidine; ErbB Receptors; Fluorouracil; Humans; Irinotecan; Leucovorin; Mitomycin; Mutation; Organoplatinum Compounds; Oxaloacetates; Panitumumab; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Vascular Endothelial Growth Factor A

2012
New oxaliplatin-based combinations in the treatment of colorectal cancer.
    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2003, Volume: 5 Suppl 3

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Boronic Acids; Bortezomib; Camptothecin; Capecitabine; Cetuximab; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Gefitinib; Humans; Irinotecan; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Pyrazines; Quinazolines; Thiophenes

2003
Advances in the Management of Anal Cancer.
    Current oncology reports, 2016, Volume: 18, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Cisplatin; Female; Fluorouracil; Humans; Induction Chemotherapy; Mass Screening; Mitomycin; Papillomavirus Infections; Papillomavirus Vaccines; Radiation Dosage; Radiotherapy, Intensity-Modulated

2016
Mitomycin-C+fluoropyrimidines in heavily pretreated metastatic colorectal cancer: a systematic review and evidence synthesis.
    Anti-cancer drugs, 2016, Volume: 27, Issue:6

    Topics: Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Fluorouracil; Humans; Mitomycin; Treatment Outcome

2016
[Rectal squamous cell carcinoma treatment: Retrospective experience in two French university hospitals, review and proposals].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2016, Volume: 20, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Clinical Trials as Topic; Colostomy; Combined Modality Therapy; Female; Fluorouracil; France; Hospitals, University; Humans; Male; Middle Aged; Mitomycin; Positron Emission Tomography Computed Tomography; Radiodermatitis; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Retrospective Studies; Skin Ulcer; Survival Rate; Treatment Outcome

2016
Capecitabine in locally advanced anal cancer, do we need randomised evidence?
    Expert review of anticancer therapy, 2017, Volume: 17, Issue:5

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Chemoradiotherapy; Fluorouracil; Humans; Mitomycin; Randomized Controlled Trials as Topic; Treatment Outcome

2017
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    The Cochrane database of systematic reviews, 2018, Apr-06, Volume: 4

    Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Cholangiocarcinoma; Cisplatin; Deoxycytidine; Drug Combinations; Female; Gallbladder Neoplasms; Gemcitabine; Humans; Male; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Piperidines; Quinazolines; Randomized Controlled Trials as Topic; Tegafur

2018
Executive Summary of the American Radium Society Appropriate Use Criteria for Treatment of Anal Cancer.
    International journal of radiation oncology, biology, physics, 2019, 11-01, Volume: 105, Issue:3

    Topics: Anal Canal; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Consensus; Delphi Technique; ErbB Receptors; Female; Humans; Male; Margins of Excision; Mitomycin; Precision Medicine; Radiotherapy; Salvage Therapy; Sex Factors; Societies, Medical; Treatment Outcome; United States

2019
Comparison of intravenous 5-Fluorouracil with Oral Capecitabine in the Treatment of Anal Squamous Cell Carcinoma Using Modern Radiation Techniques.
    The Israel Medical Association journal : IMAJ, 2023, Volume: 25, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Fluorouracil; Humans; Mitomycin

2023

Trials

29 trial(s) available for mitomycin and capecitabine

ArticleYear
Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Bone Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Liver Neoplasms; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitomycin; Neoplasm Staging; Treatment Outcome

2004
Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial.
    British journal of cancer, 2004, Aug-31, Volume: 91, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Maximum Tolerated Dose; Middle Aged; Mitomycin; Treatment Outcome

2004
Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer.
    British journal of cancer, 2004, Aug-31, Volume: 91, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Dose-Response Relationship, Drug; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Mitomycin; Survival Analysis; Treatment Outcome

2004
[Capecitabine combined with TACE for advanced liver cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2004, Volume: 26, Issue:9

    Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemoembolization, Therapeutic; Combined Modality Therapy; Deoxycytidine; Drug Administration Schedule; Female; Fluorouracil; Humans; Liver Neoplasms; Male; Middle Aged; Mitomycin

2004
Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease Progression; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Survival Analysis; Treatment Outcome

2005
Capecitabine and mitomycin C as third-line therapy for patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.
    British journal of cancer, 2005, Sep-05, Volume: 93, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Irinotecan; Male; Middle Aged; Mitomycin; Salvage Therapy; Survival Rate; Treatment Outcome

2005
Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.
    Oncology, 2006, Volume: 70, Issue:4

    Topics: Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoplasm Metastasis; Survival Analysis; Taxoids; Treatment Outcome

2006
Capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated tumours: results of an extended phase-I trial.
    British journal of cancer, 2007, Dec-03, Volume: 97, Issue:11

    Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Diarrhea; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Infusions, Intravenous; Leukopenia; Male; Middle Aged; Mitomycin; Nausea; Neoplasms; Skin Diseases; Taxoids; Treatment Outcome; Vomiting

2007
EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
    International journal of radiation oncology, biology, physics, 2008, Sep-01, Volume: 72, Issue:1

    Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Diarrhea; Drug Administration Schedule; Feasibility Studies; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neutropenia; Radiotherapy Dosage; Remission Induction; United Kingdom

2008
A phase II study evaluating the use of concurrent mitomycin C and capecitabine in patients with advanced unresectable pseudomyxoma peritonei.
    British journal of cancer, 2008, Aug-19, Volume: 99, Issue:4

    Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CA-125 Antigen; CA-19-9 Antigen; Capecitabine; Carcinoembryonic Antigen; Deoxycytidine; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Peritoneal Neoplasms; Pseudomyxoma Peritonei; Quality of Life; Survival Rate; Treatment Outcome

2008
A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies.
    Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:5

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Male; Middle Aged; Mitomycin

2010
Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
    Journal of cancer research and clinical oncology, 2010, Volume: 136, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Capecitabine; Deoxycytidine; Diarrhea; Disease-Free Survival; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Gallbladder Neoplasms; Humans; Leukopenia; Male; Middle Aged; Mitomycin; Pancreatic Neoplasms; Taxoids; Treatment Outcome

2010
Preoperative capecitabine and pelvic radiation in locally advanced rectal cancer--is it equivalent to 5-FU infusion plus leucovorin and radiotherapy?
    International journal of radiation oncology, biology, physics, 2010, Volume: 76, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Female; Fluorouracil; Humans; Leucovorin; Male; Matched-Pair Analysis; Middle Aged; Mitomycin; Neoadjuvant Therapy; Preoperative Care; Radiotherapy Dosage; Rectal Neoplasms; Remission Induction; Retrospective Studies; Survival Rate; Therapeutic Equivalency

2010
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Jul-01, Volume: 28, Issue:19

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Australasia; Bevacizumab; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Diarrhea; Female; Fluorouracil; Humans; Hypotension; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Quality of Life; Thrombocytopenia; Treatment Outcome

2010
Preoperative radiotherapy with capecitabine and mitomycin C in locally advanced rectal carcinoma.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Combined Modality Therapy; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Prospective Studies; Rectal Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Survival; Treatment Outcome

2011
Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer.
    Neoplasma, 2011, Volume: 58, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Female; Fluorouracil; Humans; Middle Aged; Mitomycin; Neoplasm Metastasis

2011
Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jul-01, Volume: 29, Issue:19

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Deoxycytidine; DNA Mutational Analysis; Female; Fluorouracil; Genes, ras; Humans; Male; Middle Aged; Mitomycin; Mutation; Proto-Oncogene Proteins B-raf; ras Proteins; Treatment Outcome

2011
Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
    International journal of radiation oncology, biology, physics, 2013, Apr-01, Volume: 85, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Combined Modality Therapy; Cytidine Deaminase; Deoxycytidine; Diarrhea; Dihydrouracil Dehydrogenase (NADP); Dose Fractionation, Radiation; Fatigue; Feasibility Studies; Female; Fluorouracil; Glutathione S-Transferase pi; Humans; Infusions, Intravenous; Lymphatic Metastasis; Male; Maximum Tolerated Dose; Middle Aged; Mitomycin; Pain; Polymorphism, Genetic; Radiodermatitis; Radiotherapy, Intensity-Modulated

2013
Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab.
    Cancer medicine, 2013, Volume: 2, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; DNA Copy Number Variations; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Prognosis; PTEN Phosphohydrolase; ras Proteins

2013
The cost effectiveness of bevacizumab when added to capecitabine, with or without mitomycin-C, in first line treatment of metastatic colorectal cancer: results from the Australasian phase III MAX study.
    European journal of cancer (Oxford, England : 1990), 2014, Volume: 50, Issue:3

    Topics: Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Australia; Bevacizumab; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Mitomycin; Quality of Life; Treatment Outcome

2014
Mitomycin C and capecitabine in pretreated patients with metastatic gastric cancer: a multicenter phase II study.
    Journal of cancer research and clinical oncology, 2014, Volume: 140, Issue:5

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Stomach Neoplasms; Treatment Outcome

2014
Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer.
    British journal of cancer, 2015, Mar-17, Volume: 112, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Class I Phosphatidylinositol 3-Kinases; Colorectal Neoplasms; Deoxycytidine; DNA, Neoplasm; Female; Fluorouracil; Genes, ras; Humans; Male; Mitomycin; Mutation; Phosphatidylinositol 3-Kinases; Prognosis

2015
Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.
    British journal of cancer, 2015, Jun-30, Volume: 113, Issue:1

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Mitomycin; Neoplasm Metastasis; Vascular Endothelial Growth Factor D

2015
Capecitabine with/without mitomycin C: results of a randomized phase II trial of second-line therapy in advanced biliary tract adenocarcinoma.
    Cancer chemotherapy and pharmacology, 2016, Volume: 77, Issue:1

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Disease-Free Survival; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Mitomycin; Neoplasm Staging; Thymidine Phosphorylase; Thymidylate Synthase; Treatment Outcome

2016
Phase II Study of Capecitabine in Substitution of 5-FU in the Chemoradiotherapy Regimen for Patients with Localized Squamous Cell Carcinoma of the Anal Canal.
    Journal of gastrointestinal cancer, 2016, Volume: 47, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Remission Induction; Survival Rate

2016
Efficacy and safety of helical tomotherapy with daily image guidance in anal canal cancer patients.
    Acta oncologica (Stockholm, Sweden), 2016, Volume: 55, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Colostomy; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Radiotherapy, Image-Guided; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome

2016
The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 11-01, Volume: 29, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Capecitabine; Colorectal Neoplasms; Female; Gene Expression Profiling; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Prognosis; Progression-Free Survival; Transcriptome

2018
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases: A Phase 2 Randomized Clinical Trial.
    JAMA surgery, 2021, 08-01, Volume: 156, Issue:8

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms; Cytoreduction Surgical Procedures; Feasibility Studies; Female; Fluorouracil; Humans; Hyperthermic Intraperitoneal Chemotherapy; Leucovorin; Male; Middle Aged; Mitomycin; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Perioperative Period; Peritoneal Neoplasms; Response Evaluation Criteria in Solid Tumors

2021
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer.
    European urology, 2022, Volume: 82, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Capecitabine; Chemoradiotherapy; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Mitomycin; Muscles; Nivolumab; Urinary Bladder Neoplasms

2022

Other Studies

27 other study(ies) available for mitomycin and capecitabine

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?
    Onkologie, 2003, Volume: 26, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Squamous Cell; Deoxycytidine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Activation; Esophageal Neoplasms; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Thymidine Phosphorylase; Treatment Outcome

2003
Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C.
    Journal of surgical oncology, 2006, Jan-01, Volume: 93, Issue:1

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Disease-Free Survival; Female; Floxuridine; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Mitomycin; Rectal Neoplasms; Thymidine Phosphorylase; Up-Regulation

2006
Capecitabine and mitomycin C in patients with metastatic colorectal cancer resistant to fluorouracil and irinotecan.
    British journal of cancer, 2006, Mar-27, Volume: 94, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Fluorouracil; Humans; Mitomycin; Neoplasm Metastasis; Patient Selection; Prognosis; Reproducibility of Results; Treatment Outcome

2006
Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
    Journal of cardiothoracic and vascular anesthesia, 2007, Volume: 21, Issue:2

    Topics: Adult; Anesthesia, General; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Deoxycytidine; Fluorouracil; Humans; Hyperthermia, Induced; Intraoperative Period; Male; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Pleural Neoplasms; Pseudomyxoma Peritonei; Thoracic Surgical Procedures

2007
Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation.
    International journal of radiation oncology, biology, physics, 2009, May-01, Volume: 74, Issue:1

    Topics: Adenocarcinoma; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Fluorodeoxyglucose F18; Fluorouracil; Humans; Mitomycin; Neoadjuvant Therapy; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Statistics, Nonparametric

2009
HIV and anal cancer outcomes: a single institution's experience.
    Diseases of the colon and rectum, 2009, Volume: 52, Issue:5

    Topics: Antineoplastic Agents; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Cisplatin; Colostomy; Deoxycytidine; Female; Fluorouracil; HIV Infections; Humans; Male; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Radiotherapy, Adjuvant; Retrospective Studies

2009
MK-1775, a small molecule Wee1 inhibitor, enhances anti-tumor efficacy of various DNA-damaging agents, including 5-fluorouracil.
    Cancer biology & therapy, 2010, Apr-01, Volume: 9, Issue:7

    Topics: Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Camptothecin; Capecitabine; Caspases; Cell Cycle Proteins; Cell Proliferation; Colonic Neoplasms; Deoxycytidine; DNA Damage; Doxorubicin; Flow Cytometry; Fluorouracil; Glutamates; Guanine; Histones; Humans; Immunoenzyme Techniques; Mitomycin; Nuclear Proteins; Pemetrexed; Phosphorylation; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Pyrimidinones; Rats; Rats, Inbred F344; Rats, Nude; Xenograft Model Antitumor Assays

2010
Chemoradiotherapy for anal cancer in HIV patients causes prolonged CD4 cell count suppression.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Cell Survival; Chemoradiotherapy; Deoxycytidine; Female; Fluorouracil; HIV Infections; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin

2012
Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?
    Radiation oncology (London, England), 2012, Nov-29, Volume: 7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cisplatin; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Time Factors

2012
Mitomycin-C and capecitabine (MIXE) as salvage treatment in patients with refractory metastatic colorectal cancer: a retrospective study.
    Anticancer research, 2013, Volume: 33, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Disease Progression; Drug Resistance, Neoplasm; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Neoplasm Metastasis; Retrospective Studies; Salvage Therapy; Treatment Outcome

2013
Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
    Journal of gastroenterology and hepatology, 2013, Volume: 28, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Capecitabine; Chemotherapy, Adjuvant; Cholangiocarcinoma; Deoxycytidine; Drug Evaluation; Female; Fluorouracil; Gemcitabine; Humans; Male; Middle Aged; Mitomycin; Neoplasm Grading; Neoplasm Staging; Retrospective Studies; Survival Analysis; Treatment Outcome

2013
Intensity-modulated Radiation Therapy for Anal Cancer: Results From a Multi-Institutional Retrospective Cohort Study.
    American journal of clinical oncology, 2016, Volume: 39, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Cohort Studies; Female; Fluorouracil; Gastrointestinal Diseases; Humans; Lymph Nodes; Male; Middle Aged; Mitomycin; Neoplasm Staging; Radiation Injuries; Radiodermatitis; Radiotherapy, Intensity-Modulated; Retrospective Studies; Treatment Outcome

2016
Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma.
    Radiation oncology (London, England), 2014, May-29, Volume: 9

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Retrospective Studies

2014
Fat composition changes in bone marrow during chemotherapy and radiation therapy.
    International journal of radiation oncology, biology, physics, 2014, Sep-01, Volume: 90, Issue:1

    Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Capecitabine; Cervical Vertebrae; Cetuximab; Chemoradiotherapy; Cisplatin; Deoxycytidine; Endometrial Neoplasms; Female; Fluorouracil; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Middle Aged; Mitomycin; Paclitaxel; Prospective Studies; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Spine; Thoracic Vertebrae; Uterine Cervical Neoplasms

2014
Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.
    British journal of cancer, 2014, Oct-28, Volume: 111, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Deoxycytidine; Female; Fluorouracil; Follow-Up Studies; Humans; Male; Middle Aged; Mitomycin; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate

2014
O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
    Oncology, 2014, Volume: 87, Issue:6

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Esophageal Neoplasms; Female; Fluorouracil; Haptoglobins; Hematologic Diseases; Hemolytic-Uremic Syndrome; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Mitomycin; Organoplatinum Compounds; Oxaliplatin; Remission Induction; Stomach Neoplasms; Treatment Outcome

2014
Mitomycin C and Capecitabine (MiX Trial) for Therapy of Patients with Metastasized, Breast Cancer Pretreated with Anthracycline.
    Anticancer research, 2016, Volume: 36, Issue:1

    Topics: Anthracyclines; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Breast Neoplasms; Capecitabine; Female; Humans; Middle Aged; Mitomycin; Neoplasm Metastasis

2016
Management for Peritoneal Metastasis of Colonic Origin: Role of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy: A Single Institution's Experience During Two Decades.
    Annals of surgical oncology, 2017, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; CA-125 Antigen; Capecitabine; Chemotherapy, Adjuvant; Colonic Neoplasms; Cytoreduction Surgical Procedures; Female; Fluorouracil; Follow-Up Studies; Humans; Infusions, Parenteral; Male; Middle Aged; Mitomycin; Mucin-1; Neoadjuvant Therapy; Neoplasm, Residual; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Retrospective Studies; Survival Rate; Young Adult

2017
Hematologic Nadirs During Chemoradiation for Anal Cancer: Temporal Characterization and Dosimetric Predictors.
    International journal of radiation oncology, biology, physics, 2017, 02-01, Volume: 97, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Bone Marrow; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Drug Administration Schedule; Female; Fluorouracil; Humans; Ilium; Leukopenia; Male; Middle Aged; Mitomycin; Neutropenia; Pelvic Bones; Radiotherapy Dosage; Radiotherapy, Conformal; Radiotherapy, Intensity-Modulated; Retrospective Studies; Thrombocytopenia; Time Factors

2017
Toxicity, Tolerability, and Compliance of Concurrent Capecitabine or 5-Fluorouracil in Radical Management of Anal Cancer With Single-dose Mitomycin-C and Intensity Modulated Radiation Therapy: Evaluation of a National Cohort.
    International journal of radiation oncology, biology, physics, 2018, 08-01, Volume: 101, Issue:5

    Topics: Adenocarcinoma; Aged; Anus Neoplasms; Capecitabine; Carcinoma, Squamous Cell; Chemoradiotherapy; Cohort Studies; Combined Modality Therapy; Disease-Free Survival; Female; Fluorouracil; Humans; Male; Middle Aged; Mitomycin; Patient Compliance; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Recurrence; Treatment Outcome; United Kingdom

2018
Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.
    Radiation oncology (London, England), 2018, Sep-10, Volume: 13, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Capecitabine; Chemoradiotherapy; Female; Fluorouracil; France; Humans; Italy; Male; Middle Aged; Mitomycin; Proportional Hazards Models; Radiotherapy, Intensity-Modulated; Retrospective Studies

2018
Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2020, Volume: 150

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Fluorouracil; Humans; Mitomycin; Muscles; Neoplasm Recurrence, Local; Tablets; Urinary Bladder Neoplasms

2020
Colorectal cancer cells from patients treated with FOLFOX or CAPOX are resistant to oxaliplatin.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2021, Volume: 47, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Capecitabine; Colorectal Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Humans; Hyperthermic Intraperitoneal Chemotherapy; Irinotecan; Leucovorin; Mitomycin; Neoadjuvant Therapy; Organoplatinum Compounds; Oxaliplatin; Peritoneal Neoplasms; Primary Cell Culture; Tumor Cells, Cultured

2021
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin.
    Clinical colorectal cancer, 2023, Volume: 22, Issue:4

    Topics: Appendiceal Neoplasms; Bevacizumab; Capecitabine; Disease Progression; Humans; Hyperthermia, Induced; Mitomycin; Peritoneal Neoplasms; Prospective Studies; Pseudomyxoma Peritonei

2023
Capecitabine/Mitomycin versus 5-Fluorouracil/Mitomycin in Combination with Simultaneous Integrated Boost Intensity-Modulated Radiation Therapy for Anal Cancer.
    Current oncology (Toronto, Ont.), 2023, 09-18, Volume: 30, Issue:9

    Topics: Anus Neoplasms; Capecitabine; Cohort Studies; Fluorouracil; Humans; Mitomycin; Prospective Studies; Radiotherapy, Intensity-Modulated

2023